Citation record · dewpoint-2026-dewpoint-therapeutics-doses

Dewpoint Therapeutics, Dewpoint Therapeutics doses first patient in Phase 1a/2a trial DPTX3186 for the treatment of advanced solid tumors, focused on gastric cancer — company press release (2026) (sponsor’s own figures)

program 2026 not re-checked

Authors. Dewpoint Therapeutics

Venue. — company press release (sponsor’s own figures)

How the Institute flags it

frontier 1 time

The evidence base